| Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients Antithrombotic Trialists' Collaboration Bmj 324 (7329), 71-86, 2002 | 13385* | 2002 |
| Platelet activation and atherothrombosis G Davì, C Patrono New England Journal of Medicine 357 (24), 2482-2494, 2007 | 2708 | 2007 |
| In Vivo Formation of 8-Iso-Prostaglandin F2α and Platelet Activation in Diabetes Mellitus: Effects of Improved Metabolic Control and Vitamin E Supplementation G Davı̀, G Ciabattoni, A Consoli, A Mezzetti, A Falco, S Santarone, ... Circulation 99 (2), 224-229, 1999 | 998 | 1999 |
| Thromboxane biosynthesis and platelet function in type II diabetes mellitus G Davì, I Catalano, M Averna, A Notarbartolo, A Strano, G Ciabattoni, ... New England Journal of Medicine 322 (25), 1769-1774, 1990 | 852 | 1990 |
| Platelet activation in obese women: role of inflammation and oxidant stress G Davì, MT Guagnano, G Ciabattoni, S Basili, A Falco, M Marinopiccoli, ... Jama 288 (16), 2008-2014, 2002 | 750 | 2002 |
| A comparison of five maintenance therapies for reflux esophagitis S Vigneri, R Termini, G Leandro, S Badalamenti, M Pantalena, V Savarino, ... New England Journal of Medicine 333 (17), 1106-1110, 1995 | 748 | 1995 |
| Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels JA Wedzicha, TAR Seemungal, PK MacCallum, EA Paul, GC Donaldson, ... Thrombosis and haemostasis 84 (08), 210-215, 2000 | 630 | 2000 |
| Platelet activation in type 2 diabetes mellitus P Ferroni, S Basili, A Falco, G Davi Journal of Thrombosis and Haemostasis 2 (8), 1282-1291, 2004 | 584 | 2004 |
| Clinical pharmacology of platelet cyclooxygenase inhibition. C Patrono, G Ciabattoni, P Patrignani, F Pugliese, P Filabozzi, F Catella, ... Circulation 72 (6), 1177-1184, 1985 | 565 | 1985 |
| Lipid peroxidation in diabetes mellitus G Davì, A Falco, C Patrono Antioxidants & redox signaling 7 (1-2), 256-268, 2005 | 557 | 2005 |
| In Vivo Formation of 8-Epi-Prostaglandin F2α Is Increased in Hypercholesterolemia G Davi, P Alessandrini, A Mezzetti, G Minotti, T Bucciarelli, F Costantini, ... Arteriosclerosis, thrombosis, and vascular biology 17 (11), 3230-3235, 1997 | 469 | 1997 |
| Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia A Notarbartolo, G Davı̀, M Averna, CM Barbagallo, A Ganci, ... Arteriosclerosis, thrombosis, and vascular biology 15 (2), 247-251, 1995 | 389 | 1995 |
| Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus P Gresele, G Guglielmini, M De Angelis, S Ciferri, M Ciofetta, E Falcinelli, ... Journal of the American college of Cardiology 41 (6), 1013-1020, 2003 | 373 | 2003 |
| Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina F Cipollone, G Ciabattoni, P Patrignani, M Pasquale, D Di Gregorio, ... Circulation 102 (9), 1007-1013, 2000 | 339 | 2000 |
| Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy F Cipollone, A Mezzetti, E Porreca, C Di Febbo, M Nutini, M Fazia, A Falco, ... Circulation 106 (4), 399-402, 2002 | 318 | 2002 |
| Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo: evidence derived from the … G Davı̀, P Gresele, F Violi, S Basili, M Catalano, C Giammarresi, ... Circulation 96 (1), 69-75, 1997 | 314 | 1997 |
| Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin “resistance” F Santilli, B Rocca, R De Cristofaro, S Lattanzio, L Pietrangelo, A Habib, ... Journal of the American College of Cardiology 53 (8), 667-677, 2009 | 308 | 2009 |
| Diabetes mellitus and thrombosis N Vazzana, P Ranalli, C Cuccurullo, G Davì Thrombosis research 129 (3), 371-377, 2012 | 289 | 2012 |
| Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study GE Carlsson, A Möller, C Blomstrand, T Ueda, K Mizushige, K Yukiiri, ... Cerebrovascular Diseases 16 (4), 389-395, 2003 | 289 | 2003 |
| The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low‐dose aspirin in patients with and without diabetes B Rocca, F Santilli, D Pitocco, L Mucci, G Petrucci, E Vitacolonna, ... Journal of Thrombosis and Haemostasis 10 (7), 1220-1230, 2012 | 280 | 2012 |
